AbClon

About:

AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden.

Website: http://abclon.com/

Top Investors: IMM Investment, Shinhan Capital, Quad Asset Management, FOCUS ASSET MANAGEMENT

Description:

Total Funding Amount:

22B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seoul, Seoul-t'ukpyolsi, South Korea

Founded Date:

2010-01-01

Contact Email:

abclon(AT)abclon.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2022-07-27

IPO Status:

Private

Industries: